Lung cancer
Lung cancer kills about 2 million people annually — more than any other cancer. But the development of more-effective therapies and means of diagnosis provide some glimmers of hope.
This Nature Outlook is editorially independent, produced with financial support from a third party. About this content.
Nature is pleased to acknowledge financial support from Janssen Pharmaceutical Companies of Johnson & Johnson in producing this Outlook. The sponsor retains sole responsibility for the following message.
About the Janssen Pharmaceutical Companies of Johnson & Johnson
Janssen is striving to create a future where disease is a thing of the past. Janssen is one of the pharmaceutical companies of Johnson & Johnson, and its researchers are working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. The company focuses on areas of medicine where it can make the biggest difference: cardiovascular & metabolism, immunology, infectious diseases & vaccines, neuroscience, oncology, and pulmonary hypertension.
Learn more at www.janssen.com. Follow Janssen at www.twitter.com/JanssenGlobal.
Janssen Pharmaceutical K.K. is one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
